Showing results (1011-1020 of 2,641) with videos related to

Sort By:
Pageof 265
Hematology (Amsterdam, Netherlands)|April 23, 2013
Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletionOscar González-Llano, Laura Nelly Rodríguez-Romo, María del Consuelo Mancías-Guerra, et al.
Hematology (Amsterdam, Netherlands)|April 2, 2013
Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistanceBahram Chahardouli, Farhad Zaker, Seied Asadollah Mousavi, et al.
Hematology (Amsterdam, Netherlands)|April 2, 2013
The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopeniaZhong Wu, Jin Zhou, Xiaoxia Wei, et al.
Hematology (Amsterdam, Netherlands)|April 2, 2013
EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylateBurak Uz, Yahya Buyukasik, Hilmi Atay, et al.
Hematology (Amsterdam, Netherlands)|February 12, 2013
Outcome of childhood acute Lymphoblastic leukemia in Egyptian children: a challenge for limited health resource countriesAzza A G Tantawy, Farida H El-Rashidy, Iman A Ragab, et al.
Hematology (Amsterdam, Netherlands)|February 12, 2013
Alloantibodies in previously untreated hemophilia A patients: the role of environmental factorsMassimo Franchini, Francesco Frattini, Silvia Crestani, et al.
Hematology (Amsterdam, Netherlands)|February 12, 2013
Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?Ahmed M L Bedewy, Shereen M El-Maghraby
Hematology (Amsterdam, Netherlands)|February 26, 2013
Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin AZhen Yu Li, Qingyun Wu, Zhiling Yan, et al.
Hematology (Amsterdam, Netherlands)|February 26, 2013
Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemiaCesar Homero Gutierrez-Aguirre, Fernando Garcia-Rodriguez, Victor Manuel Ortiz-Galvez, et al.
Hematology (Amsterdam, Netherlands)|January 17, 2013
Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experienceAkinao Okamoto, Masamitsu Yanada, Yoko Inaguma, et al.
Pageof 265